The Science Behind Us - Clinical Research List

Lactobacillus* fermentum CECT5716 (Qiara) is a single probiotic strain originally isolated from human breastmilk
(*Recently reclassified to Limosilactobacillus fermentum CECT5716)

Find Accredited Clinical Education, Case Studies, Product Training, Product Tech Sheets and more in our Health Professional Portal:

 Register Here for the Health Professional Portal

Lactobacillus fermentum CECT5716 - The Qiara Strain

(13 articles)

Limosilactobacillus fermentum CECT5716: Clinical Potential of a Probiotic Strain Isolated from Human Milk 2023 - view article

Limosilactobacillus fermentum CECT5716: Mechanisms and Therapeutic Insights. 2021 - view article

Evaluation of the Effect of Limosilactobacillus fermentum CECT5716 on Gastrointestinal Infections in Infants: A Systematic Review and Meta-Analysis 2021 - view article

Beneficial Effects of Limosilactobacillus fermentum CECT 5716 Administration to Infants Delivered by Cesarean Section 2022 - view article

Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial - view article

Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health 2020 - view article

Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263 2019 - view article

Oral fermentum CECT5716 Prevents Lactational Mastitis Development 2017 - view article

Lactobacillus fermentum CECT 5716 Reduces Staphylococcus Load in the Breastmilk of Lactating Mothers Suffering Breast Pain 2015 - view article

Human Milk Probiotic Lactobacillus fermentum CECT5716 Reduces the Incidence of Gastrointestinal and Upper Respiratory Tract Infections in Infants 2012 - view article

Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age 2011 - view article

Treatment of Infectious Mastitis during Lactation: Antibiotics versus Oral Administration of Lactobacilli Isolated from Breast Milk 2010 - view article

Efficacy of Single-Strain Probiotics Versus Multi-Strain Mixtures: Systematic Review of Strain and Disease Specificity - PubMed (nih.gov) - view article

Medication Use & The Microbiome

(5 articles)

Long-term Ecological Impacts of Antibiotic Administration on the Human Intestinal Microbiota - view article

Short-Term Antibiotic Treatment Has Differing Long-Term Impacts on the Human Throat and Gut Microbiome - view article

Impact of commonly used drugs on the composition and metabolic function of the gut microbiota - view article

Proton pump inhibitors affect the gut microbiome - view article

The influence of proton pump inhibitors and other commonly used medication on the gut microbiota - view article

Evidence for Probiotic Strain Specificity

(5 articles)

Probiotics to prevent Staphylococcus aureus disease? - view article

Evidence of Probiotic Strain Specificity Makes Extrapolation of Results Impossible From a Strain to Another, Even From the Same Species - view article

Efficacy of Single-Strain Probiotics Versus Multi-Strain Mixtures: Systematic Review of Strain and Disease Specificity - view article

Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis - view article

Probiotics in human milk and probiotic supplementation in infant nutrition: a workshop report British Journal of Nutrition (2014). - view article

More Articles

Lactobacillus fermentum and its potential immunomodulatory properties 2019 - view article